Does Rallies show 13F holders for ERNA?

Yes. Rallies tracks hedge fund and 13F ownership data for ERNA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ERNA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ERNA. It does not provide personalized investment advice.

ERNA (Ernexa Therapeutics Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Ernexa Therapeutics Inc. Common Stock (ERNA) is a publicly traded Healthcare sector company. As of May 20, 2026, ERNA trades at $11.24 with a market cap of $14.29M and a P/E ratio of -4.92. ERNA moved +0.00% today. Year to date, ERNA is -60.52%; over the trailing twelve months it is -86.72%. Its 52-week range spans $3.18 to $558.75. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces ERNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ERNA stock?

Hedge funds tracked by Rallies that own ERNA include Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ernexa Therapeutics Inc. Common Stock.

ERNA Key Metrics

Key financial metrics for ERNA
Metric	Value
Price	$11.24
Market Cap	$14.29M
P/E Ratio	-4.92
EPS	$-2.24
Dividend Yield	0.00%
52-Week High	$558.75
52-Week Low	$3.18
Volume	51.55K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-14.08M
Gross Margin	0.00%

Top Hedge Funds Holding ERNA

Two Sigma holds 29.74K shares of ERNA, changed -9.51% as of Dec 31, 2024.

Latest ERNA News

Ernexa’s ERNA-101 Achieves 100% Tumor Elimination in Preclinical Ovarian Models — May 20, 2026
Ernexa Showcases ERNA-101 in KOL Segment and Highlights 100% Survival Preclinical Data — May 11, 2026
Ernexa Therapeutics Plans 1-for-25 Reverse Stock Split to Meet Nasdaq’s $1.00 Rule — Apr 30, 2026
Ernexa Advances ERNA-101 Toward Q3 2026 IND, Backed by $10.5 M Financing — Mar 31, 2026
Ernexa Therapeutics Raises $10.5M via 21M-Share, $0.50 Offering with $0.68 Warrants — Feb 6, 2026

Recent ERNA Insider Trades

Cherington Charles bought 4.00M (~$2.00M) on Feb 10, 2026.
Cherington Charles bought 21.24M (~$2.22M) on Jun 9, 2025.
Cherington Charles bought 3.77M (~$394.17K) on Apr 2, 2025.

ERNA Analyst Consensus

1 analysts cover ERNA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.

Common questions about ERNA

Who owns ERNA stock?: Hedge funds tracked by Rallies that own ERNA include Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ernexa Therapeutics Inc. Common Stock.
Does Rallies show 13F holders for ERNA?: Yes. Rallies tracks hedge fund and 13F ownership data for ERNA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ERNA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ERNA. It does not provide personalized investment advice.